6-Chloro-1H-indazole

Catalog No.: 
ACEBPY032
CAS No.: 
698-25-9
Molecular Formula: 
C7H5ClN2
Molecular Weight: 
152.58
6-Chloro-1H-indazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$56.00In stockIn stock
100g98%$146.00In stockIn stock
500g98%$708.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Chloro-1H-indazole
IUPAC Name6-chloro-1H-indazole
MDL No.MFCD07774234
Molecular FormulaC7H5ClN2
Molecular Weight152.58
SMILESC1=C(Cl)C=CC2=C1[NH]N=C2
InChI KeyVUZQHUVRBPILAX-UHFFFAOYSA-N
Synonym1H-Indazole, 6-chloro- | NSC92743 | NSC-92743 | PB34228 | J-518490 | SY040590 | SCHEMBL3533806 | MFCD07774234 | AM20041034 | BDBM50209236 | 6-Chloro-1H-indazole | CS-W005017 | EN300-107312 | 6-Chloro-1H-indazole, AldrichCPR | PD182872 | FT-0646490 | BBL10
CAS No.698-25-9
PubChem CID417524

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACEBPY032 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGSFJ730 route compound structure diagram
    ACGSFJ73061072-56-8In Stock
  4. Then
  5. ACEBPY032 route product structure diagram
    ACEBPY032698-25-9In Stock
Inquiry

2. ACEBPY032 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEBPY032 route product structure diagram
    ACEBPY032698-25-9In Stock
Inquiry

3. ACEBPY032 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEBPY032 route product structure diagram
    ACEBPY032698-25-9In Stock
Inquiry

Comments (0)